PCSK9 Forum is made possible thanks to support from AstraZeneca, LIB Therapeutics, Novartis and Sanofi, all of whom have no influence or control over editorial content. More information is available here »

Already a member? Become a member Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates

Nabil G. Seidah Articles

PCSK9 and PCSK7: A tale of two non-identical twins in the regulation of cardiovascular disease and immune function

PCSK9 and PCSK7: A tale of two non-identical twins in the regulation of cardiovascular disease and immune function

Reports from the 23rd Virtual Closed Scientific Expert Meeting of the Editorial Board Dr Nabil G. Seidah   Supporters of the 23rd Scientific Expert Meeting of the Editorial Board AstraZeneca has provided a grant towards this independent project and has had no involvement in its creation…

read more »
Posted on 22 October 2025 | Posted by Nabil G. Seidah | Posted in 23rd Closed Scientific Expert Meeting of the Editorial Board
Keynote – History of PCSK9

Keynote – History of PCSK9

Reports from the 15th Virtual Closed Scientific Expert Meeting of the Editorial Board  Professor Nabil Seidah 

read more »
Posted on 17 December 2021 | Posted by Nabil G. Seidah | Posted in Hot topics, 15th Closed Scientific Expert Meeting of the Editorial Board
PCSK9 expression in extrahepatic tissues: what is the potential relevance?

PCSK9 expression in extrahepatic tissues: what is the potential relevance?

Proprotein convertase subtilisin-kexin 9 (PCSK9), the last member of the proprotein convertase family (1) discovered in 2003, has been shown to be highly expressed in liver (2). Subsequent genetic studies showed that PCSK9 was related to the regulation of circulating low-density lipoprotein (LDL) cholesterol in…

read more »
Posted on 30 July 2015 | Posted by Nabil G. Seidah | Posted in From the Editors

About PCSK9 Education and Research Forum

PCSK9 Education and Research Forum is a not-for-profit organisation established by leading researchers in the fields of atherosclerosis, lipids and cardiovascular disease. Our mission is to raise awareness and knowledge of the significant role played by PCSK9 in lipid metabolism and its value as a novel therapeutic target.

Editorial Policy

Unless otherwise indicated, opinions expressed in the PCSK9 Education and Research Forum are those of the contributors. All patients should discuss their medication with their healthcare professional. Although every effort is made to ensure accuracy and avoid mistakes, no liability on the part of the PCSK9 Forum, the editors or the editorial board is accepted for the consequences of any misleading or inaccurate information.
Educational Partners and Supporters
AstraZeneca

AstraZeneca has provided a grant towards this independent project and has had no involvement in its creation or organisation.

LIB Therapeutics

Novartis

Sanofi

© Copyright 2026 PCSK9 Forum. All rights reserved